Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000228835

Medchemexpress LLC PROTAC BET degrader- 25mg | 3031993-61-7 | 25 MG
SDP

Catalog No. 5000228835
Encompass_Preferred

PROTAC BET Degrader-3 is a proteolysis-targeting chimera that links a von Hippel-Lindau (VHL) E3 ligase ligand to a BET-family ligand to induce targeted BET protein degradation. It is supplied as a light yellow solid for research use only.

  • Proteolysis-targeting chimera linking VHL and BET ligands.
  • Designed to induce targeted degradation of BET-family proteins in biochemical and cellular assays.
  • High purity suitable for research-grade experiments.
  • Available in milligram-scale quantities for early-stage research.
  • Stable as a powder at -20°C; in solution, store at -80°C for extended stability.

Catalog No. 50-002-28835 Supplier Medchemexpress LLC Supplier No. HY11422925MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

PROTAC BET Degrader-3 is a proteolysis-targeting chimera that links a von Hippel-Lindau (VHL) E3 ligase ligand to a BET-family ligand to induce targeted BET protein degradation. It is supplied as a light yellow solid for research use only.

  • Proteolysis-targeting chimera linking VHL and BET ligands.
  • Designed to induce targeted degradation of BET-family proteins in biochemical and cellular assays.
  • High purity suitable for research-grade experiments.
  • Available in milligram-scale quantities for early-stage research.
  • Stable as a powder at -20°C; in solution, store at -80°C for extended stability.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.